Taken together, these results suggest that NPxY motif mutation in LRP1 abrogates cholesterol-induced LXR activation, thereby decreasing PCSK9 expression to suppress cholesterol-induced hypercholesterolemia. This evidence concerns the gene PCSK9 and familial hypercholesterolemia.